REFERENCES
- Carmel R . Cobalamin, the stomach, and aging . Am J Clin Nutr. 1997 ; 66 ( 4 ): 750 – 9 .
- Martin DC , Francis J , Protetch J , Huff FJ . Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study . J Am Geriatr Soc. 1992 ; 40 ( 2 ): 168 – 72 .
- McCully KS . Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis . Am J Pathol. 1969 ; 56 ( 1 ): 111 – 28 .
- Welch GN , Loscalzo J . Homocysteine and atherothrombosis . N Engl J Med. 1998 ; 338 ( 15 ): 1042 – 50 .
- Lewerin C , Nilsson-Ehle H , Matousek M , Lindstedt G , Steen B . Reduction of plasma homocysteine and serum methylmalonate concentrations in apparently healthy elderly subjects after treatment with folic acid, vitamin B12 and vitamin B6: a randomised trial . Eur J Clin Nutr. 2003 ; 57 ( 11 ): 1426 – 36 .
- Food and Nutrition Board; Institute of Medicine . Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Food and Nutrition Board . Washington , DC : National Academy Press ; 1998 .
- van Asselt DZ , van den Broek WJ , Lamers CB , Corstens FH , Hoefnagels WH . Free and protein-bound cobalamin absorption in healthy middle-aged and older subjects. J Am Geriatr Soc. 1996; 44(8):949–53.
- Scarlett JD , Read H , O'Dea K . Protein-bound cobalamin absorption declines in the elderly . Am J Hematol. 1992 ; 39 ( 2 ): 79 – 83 .
- Logan RF , Elwis A , Forrest MJ , Lawrence ACK . Mechanisms of vitamin B12 deficiency in elderly inpatients . Age Aging . 1989 ; 18 : 4 – 10 .
- Ho C , Kauwell GP , Bailey LB . Practitioners' guide to meeting the vitamin B-12 recommended dietary allowance for people aged 51 years and older . J Am Diet Assoc. 1999 ; 99 ( 6 ): 725 – 7 .
- Marcuard SP , Albernaz L , Khazanie PG . Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12) . Ann Intern Med. 1994 ; 120 ( 3 ): 211 – 5 .
- Dharmarajan TS , Kanagala MR , Murakonda P , Lebelt AS , Norkus EP . Do acid-lowering agents affect vitamin B12 status in older adults? J Am Med Dir Assoc. 2008 ; 9 ( 3 ): 162 – 7 .
- Valuck RJ , Ruscin JM . A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults . J Clin Epidemiol. 2004 ; 57 ( 4 ): 422 – 8 .
- Ribaya-Mercado JD , Russell RM , Sahyoun N , Morrow FD , Gershoff SN . Vitamin B-6 requirements of elderly men and women . J Nutr. 1991 ; 121 ( 7 ): 1062 – 74 .
- Clarke R , Grimley Evans J , et al. . Vitamin B12 and folate deficiency in later life . Age Ageing 2004 ; 33 ( 1 ): 34 – 41 .
- Rampersaud GC , Kauwell GP , Bailey LB . Folate: a key to optimizing health and reducing disease risk in the elderly . J Am Coll Nutr. 2003 ; 22 ( 1 ): 1 – 8 .
- Food and Drug Administration . Final Rule . Food Standards: amendment of Standards of Identity for Enriched Grain Products to Require Addition of Folic Acid. Federal Register 1996 ; 61 : 8781 – 8797 .
- Health Canada . Regulations amending the food and drug regulations: schedule No. 1066 (flour fortification) . Canada Gazette Part II 1998 ; 132 ( 24 ).
- Garcia AA , Day AG , Zanibbi K , Zunzunegui MV . Long-term effects of folic acid fortification and B-vitamin supplementation on total folate, homocysteine, methylmalonic acid and cobalamin in older adults . Can J Public Health 2008 ; 99 ( 5 ): 428 – 33 .
- Mulligan JE , Greene GW , Caldwell M . Sources of folate and serum folate levels in older adults . J Am Diet Assoc. 2007 ; 107 ( 3 ): 495 – 9 .
- Choumenkovitch SF , Selhub J , Wilson PW , Rader JI , Rosenberg IH , Jacques PF . Folic acid intake from fortification in United States exceeds predictions . J Nutr. 2002 ; 132 ( 9 ): 2792 – 8 .
- Wakimoto P , Block G . Dietary intake, dietary patterns, and changes with age: an epidemiological perspective . J Gerontol A Biol Sci Med Sci. 2001 ; 56 ( 90002 ): 65 – 80 .
- Marshall TA , Stumbo PJ , Warren JJ , Xie XJ . Inadequate nutrient intakes are common and are associated with low diet variety in rural, community-dwelling elderly . J. Nutr . 2001 ; 131 ( 8 ): 2192 – 2196 .
- Miller JW , Green R , Mungas DM , Reed BR , Jagust WJ . Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology . 2002; 58(10):1471–1475.
- Kelly PJ , Kistler JP , et al. . Inflammation, homocysteine, and vitamin B6 status after ischemic stroke . Stroke . 2004 ; 35 ( 1 ): 12 – 15 .
- Chiang EP , Bagley PJ , Selhub J , Nadeau M , Roubenoff R . Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis . Am J Med. 2003 ; 114 ( 4 ): 283 – 7 .
- Essama-Tjani JC , Guilland JC , Potier de Courcy G , Fuchs F , Richard D . Folate status worsens in recently institutionalized elderly people without evidence of functional deterioration . J Am Coll Nutr. 2000 ; 19 : 392 – 404 .
- Rydlewicz A , Simpson JA , Taylor RJ , Bond CM , Golden MHN . The effect of folic acid supplementation on plasma homocysteine in an elderly population . QJM . 2002 ; 95 ( 1 ): 27 – 35 .
- Murúa AL , Quintana I , Janson J , Batista M , Camera MI , Kordich LC . Plasmatic homocysteine response to vitamin supplementation in elderly people . Thrombosis Research 2000 ; 100 ( 6 ): 495 – 500 .
- Bazzano LA , Reynolds K , Holder KN , He J . Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials . JAMA 2006 ; 296 ( 22 ): 2720 – 6 .
- Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis . JAMA 2002 ; 288 ( 16 ): 2015 – 22 .
- Van Guelpen B , Hultdin J , et al. . Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function . J Intern Med. 2009 ; 266 : 182 – 195 .
- Doshi SN , McDowell IF , et al. . Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering . Circulation . 2002 ; 105 ( 1 ): 22 – 6 .
- de Bree A , van Mierlo LA , Draijer R . Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials . Am J Clin Nutr. 2007 ; 86 ( 3 ): 610 – 7 .
- Lonn E . Homocysteine-lowering B vitamin therapy in cardiovascular prevention—wrong again? JAMA. 2008 ; 299 ( 17 ): 2086 – 7 .
- Toole JF , Malinow MR , et al. . Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial . JAMA . 2004 ; 291 ( 5 ): 565 – 75 .
- Bonaa KH , Njolstad I , et al. . Homocysteine lowering and cardiovascular events after acute myocardial infarction . N Engl J Med. 2006 ; 354 ( 15 ): 1578 – 88 .
- The Heart Outcomes Prevention Evaluation Investigators . Homocysteine lowering with folic acid and B vitamins in vascular disease . N Engl J Med. 2006 ; 354 ( 15 ): 1567 – 1577 .
- Albert CM , Cook NR , et al. . Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial . JAMA. 2008 ; 299 ( 17 ): 2027 – 36 .
- Ebbing M , Bleie O , et al. . Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial . JAMA . 2008 ; 300 ( 7 ): 795 – 804 .
- Martí-Carvajal A , Solà I , Lathyris D , Salanti G . Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database of Systematic Reviews 2009; (4).
- Saposnik G , Ray JG , Sheridan P , McQueen M , Lonn E . Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial . Stroke . 2009 ; 40 ( 4 ): 1365 – 72 .
- Potter K , Hankey GJ , Green DJ , Eikelboom J , Jamrozik K , Arnolda LF . The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis . BMC Cardiovasc Disord. 2008 ; 8 : 24 .
- Stroke Trials Registry . VITATOPS 2009 ; [updated 3 November 2009]. Accessed at http://www.strokecenter.org/trials/TrialDetail.aspx?tid=87 on 9 December 2009 .
- Wang X , Qin X , et al. . Efficacy of folic acid supplementation in stroke prevention: a meta-analysis . Lancet. 2007 ; 369 ( 9576 ): 1876 – 82 .
- Zoungas S , McGrath BP , et al. . Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial . J Am Coll Cardiol. 2006 ; 47 ( 6 ): 1108 – 16 .
- Vianna ACA , Mocelin AJ , et al. . Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events . Hemodialysis International . 2007 ; 11 ( 2 ): 210 – 216 .
- Jamison RL , Hartigan P , et al. . Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial . JAMA . 2007 ; 298 ( 10 ): 1163 – 1170 .
- Bowman L , Armitage J , Bulbulia R , Parish S , Collins R . Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors . Am Heart J. 2007 ; 154 ( 5 ): 815 – 23 , 823 e1–6.
- Galan P , de Bree A , et al. . Background and rationale of the SU·FOL·OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries . J Nutr Health Aging. 2003 ; 7 ( 6 ): 428 – 35 .
- Galan P , Briancon S , Blacher J , Czernichow S , Hercberg S . The SU·FOL·OM3 study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics . Trials . 2008 ; 9 : 35 .
- Raman G , Tatsioni A , et al. . Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 and B-12, and cognitive function . J Nutr. 2007 ; 137 ( 7 ): 1789 – 94 .
- Obeid R , Herrmann W . Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia . FEBS Lett. 2006 ; 580 ( 13 ): 2994 – 3005 . Epub 2006 May 6 .
- Ho PI , Collins SC , et al.. Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress. J Neurochem. 2001; 78(2):249–53.
- Luchsinger JA , Tang MX , Miller J , Green R , Mayeux R . Relation of higher folate intake to lower risk of Alzheimer disease in the elderly . Arch Neurol. 2007 ; 64 ( 1 ): 86 – 92 .
- Malouf R , Areosa Sastre A . Vitamin B12 for cognition . Cochrane Database Syst Rev. 2003 ( 3 ): CD004326 .
- Selhub J , Bagley LC , Miller J , Rosenberg IH . B vitamins, homocysteine, and neurocognitive function in the elderly . Am J Clin Nutr. 2000 ; 71 ( 2 ): 614S – 620S .
- Calvaresi E , Bryan J . B vitamins, cognition, and aging: a review . J Gerontol B Psychol Sci Soc Sci. 2001 ; 56 ( 6 ): P327 – 39 .
- Malouf R , Grimley Evans J . Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people . Cochrane Database Syst Rev. 2008 ( 4 ): CD004514 .
- Balk EM , Raman G , Tatsioni A , Chung M , Lau J , Rosenberg IH . Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials . Arch Intern Med. 2007 ; 167 ( 1 ): 21 – 30 .
- Malouf R , Grimley Evans J . The effect of vitamin B6 on cognition . Cochrane Database Syst Rev. 2003 ( 4 ): CD004393 .
- Brady CB , Gaziano JM , et al. . Homocysteine lowering and cognition in CKD: the Veterans Affairs Homocysteine Study . Am J Kidney Dis. 2009 ; 54 ( 3 ): 440 – 9 .
- Aisen PS , Schneider LS , et al. . High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial . JAMA . 2008 ; 300 ( 15 ): 1774 – 1783 .
- Sun Y , Lu CJ , Chien KL , Chen ST , Chen RC . Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients . Clin Ther. 2007 ; 29 ( 10 ): 2204 – 14 .
- Almeida OP , McCaul K , Hankey GJ , Norman P , Jamrozik K , Flicker L . Homocysteine and depression in later life . Arch Gen Psychiatry . 2008 ; 65 ( 11 ): 1286 – 94 .
- Folstein M , Liu T , et al. . The homocysteine hypothesis of depression . Am J Psychiatry . 2007 ; 164 ( 6 ): 861 – 7 .
- Gilbody S , Lightfoot T , Sheldon T . Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health . 2007 ; 61 ( 7 ): 631 – 7 .
- Merete C , Falcon LM , Tucker KL . Vitamin B6 is associated with depressive symptomatology in Massachusetts elders . J Am Coll Nutr. 2008 ; 27 ( 3 ): 421 – 7 .
- Godfrey PS , Toone BK , et al. . Enhancement of recovery from psychiatric illness by methylfolate . Lancet . 1990 ; 336 ( 8712 ): 392 – 5 .
- Hvas AM , Juul S , Lauritzen L , Nexo E , Ellegaard J . No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study . J Affect Disord. 2004 ; 81 ( 3 ): 269 – 73 .
- Coppen A , Bailey J . Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial . J Affect Disord. 2000 ; 60 ( 2 ): 121 – 30 .
- Taylor MJ , Carney SM , Goodwin GM , Geddes JR . Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol. 2004; 18(2):251–6.
- Ford AH , Flicker L , Thomas J , Norman P , Jamrozik K , Almeida OP . Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial . J Clin Psychiatry . 2008 ; 69 ( 8 ): 1203 – 9 .
- Sanjoaquin MA , Allen N , Couto E , Roddam AW , Key TJ . Folate intake and colorectal cancer risk: a meta-analytical approach . Int J Cancer . 2005 ; 113 ( 5 ): 825 – 8 .
- Cole BF , Baron JA , et al. . Folic acid for the prevention of colorectal adenomas: a randomized clinical trial . JAMA . 2007 ; 297 ( 21 ): 2351 – 2359 .
- Logan RFA , Grainge MJ , Shepherd VC , Armitage NC , Muir KR . Aspirin and folic acid for the prevention of recurrent colorectal adenomas . Gastroenterology . 2008 ; 134 ( 1 ): 29 – 38 .
- Wu K , Platz EA , et al. . A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma . Am J Clin Nutr. 2009 ; 90 ( 6 ): 1623 – 31 .
- Figueiredo JC , Grau MV , et al. . Folic acid and risk of prostate cancer: results from a randomized clinical trial . J Natl Cancer Inst . 2009 ; 101 ( 6 ): 432 – 5 .
- Zhang SM , Cook NR , Albert CM , Gaziano JM , Buring JE , Manson JE . Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial . JAMA . 2008 ; 300 ( 17 ): 2012 – 21 .
- Ebbing M , Bonaa KH , et al. . Cancer incidence and mortality after treatment with folic acid and vitamin B12 . JAMA. 2009 ; 302 ( 19 ): 2119 – 26 .
- Mason JB , Dickstein A , et al. . A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis . Cancer Epidemiol Biomarkers Prev. 2007 ; 16 ( 7 ): 1325 – 9 .
- Heuberger RA , Fisher AI , et al. . Relation of blood homocysteine and its nutritional determinants to age-related maculopathy in the third National Health and Nutrition Examination Survey . Am J Clin Nutr. 2002 ; 76 ( 4 ): 897 – 902 .
- Christen WG , Glynn RJ , Chew EY , Albert CM , Manson JE . Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study . Arch Intern Med. 2009 ; 169 ( 4 ): 335 – 41 .
- Ray JG , Vermeulen MJ , Langman LJ , Boss SC , Cole DE . Persistence of vitamin B12 insufficiency among elderly women after folic acid food fortification . Clin Biochem. 2003 ; 36 ( 5 ): 387 – 91 .
- Morris MS , Jacques PF , Rosenberg IH , Selhub J . Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification . Am J Clin Nutr. 2007 ; 85 ( 1 ): 193 – 200 .
- Bang H , Dyerberg J . Lipid metabolism and ischemic heart disease in Greenland Eskimos . In: Draper H (Ed), Advances in Nutrition Research . New York : Planum Press ; 1980 .
- Connor WE . Importance of n-3 fatty acids in health and disease1 . Am J Clin Nutr. 2000 ; 71 ( 1 ): 171S – 175 .
- Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (Macronutrients) . Washington , DC : National Academy Press ; 2005.
- Lichtenstein AH , Appel LJ , et al. . Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee . Circulation 2006 ; 114 ( 1 ): 82 – 96 .
- Mozaffarian D , Rimm EB . Fish intake, contaminants, and human health: evaluating the risks and the benefits . JAMA . 2006 ; 296 ( 15 ): 1885 – 1899 .
- GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial . Lancet. 1999 ; 354 ( 9177 ): 447 – 55 .
- Marchioli R , Barzi F , et al. . Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione . Circulation . 2002 ; 105 ( 16 ): 1897 – 903 .
- Balk EM , Lichtenstein AH , Chung M , Kupelnick B , Chew P , Lau J . Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review . Atherosclerosis . 2006 ; 189 ( 1 ): 19 – 30 .
- Friedberg CE , Janssen MJ , Heine RJ , Grobbee DE . Fish oil and glycemic control in diabetes . A meta-analysis. Diabetes Care . 1998 ; 21 ( 4 ): 494 – 500 .
- Geleijnse JM , Giltay EJ , Grobbee DE , Donders AR , Kok FJ . Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials . J Hypertens. 2002 ; 20 ( 8 ): 1493 – 9 .
- Balk EM , Lichtenstein AH , Chung M , Kupelnick B , Chew P , Lau J . Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: a systematic review . Atherosclerosis . 2006 ; 184 ( 2 ): 237 – 46 .
- Angerer P , Kothny W , Stork S , von Schacky C . Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries . Cardiovasc Res. 2002 ; 54 ( 1 ): 183 – 90 .
- Mita T , Watada H , et al. . Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes . Atherosclerosis . 2007 ; 191 ( 1 ): 162 – 7 .
- De Ley M , de Vos R , Hommes D , Stokkers P . Fish oil for induction of remission in ulcerative colitis . Cochrane Database of Systematic Reviews ; 2007 .
- Turner D , Steinhart A , Griffiths A . Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis . Cochrane Database of Systematic Reviews 2007 : CD006443 .
- Turner D , Zlotkin S , Shah P , Griffiths A . Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease . Cochrane Database of Systematic Reviews 2009 : CD006320 .
- Thien F , De Luca S , Woods R , Abramson M . Dietary marine fatty acids (fish oil) for asthma in adults and children . Cochrane Database of Systematic Reviews 2002 : CD001283 .
- Appleton KM , Peters TJ , et al. . Depressed mood and n-3 polyunsaturated fatty acid intake from fish: non-linear or confounded association? Soc Psychiatry Psychiatr Epidemiol. 2007 ; 42 ( 2 ): 100 – 4 .
- Rogers PJ , Appleton KM , et al.. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr. 2008; 99(2):421–31.
- Schaefer EJ , Bongard V , et al. . Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study . Arch Neurol. 2006 ; 63 ( 11 ): 1545 – 50 .
- van Gelder BM , Tijhuis M , Kalmijn S , Kromhout D . Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study . Am J Clin Nutr. 2007 ; 85 ( 4 ): 1142 – 7 .
- Beydoun MA , Kaufman JS , Satia JA , Rosamond W , Folsom AR . Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study . Am J Clin Nutr. 2007 ; 85 ( 4 ): 1103 – 11 .
- van de Rest O , Geleijnse JM , et al. . Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial . Neurology . 2008 ; 71 ( 6 ): 430 – 8 .
- Dangour AD . The opal study: older people and n-3 long-chain polyunsaturated fatty acids . International Standard Randomised Controlled Trial Number Register 2004 ; [cited 22 March 2009]. Accessed at http://www.controlled-trials.com/ISRCTN72331636.
- Terano T , Fujishiro S , et al. . Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases . Lipids 1999 ; 34 Suppl : S345 – 6 .
- Freund-Levi Y , Eriksdotter-Jonhagen M , et al. . Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial . Arch Neurol. 2006 ; 63 ( 10 ): 1402 – 8 .
- Foran SE , Flood JG , Lewandrowski KB . Measurement of mercury levels in concentrated over-the-counter fish oil preparations: is fish oil healthier than fish? Arch Pathol Lab Med. 2003 ; 127 ( 12 ): 1603 – 5 .
- U.S. Department of Health and Human Services and U.S. Environmental Protection Agency. What You Need to Know About Mercury in Fish and Shellfish . 2004 ; [cited 22 March 2009]. Accessed at http://www.cfsan.fda.gov/~dms/admehg3.html
- Wang C , Harris WS , et al. . n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review . Am J Clin Nutr. 2006 ; 84 ( 1 ): 5 – 17 .
- Dietrich M , Brown CJP , Block G . The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States . J Am Coll Nutr. 2005 ; 24 ( 4 ): 266 – 274 .
- Lewis CJ , Crane NT , Wilson DB , Yetley EA . Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use . Am J Clin Nutr. 1999 ; 70 ( 2 ): 198 – 207 .
- Department of Health and Human Services, Food and Drug Administration . Substances affirmed as Generally Recognized As Safe: Menhaden oil . Federal Register 1997 ; 62 : 30751 – 30757 .